(2R)-N-[(2R,3S)-3-[[(2S)-4-amino-4-oxo-2-(quinoxaline-2-carbonylamino)butanoyl]amino]-2-hydroxy-4-phenyl-butyl]-2-tert-butyl-N'-(1-ethylpropyl)butanediamide

InChIKey	`KEYGVCKWMFAJLI-CGQUYWBPSA-N`
Compound Name	(2R)-N-[(2R,3S)-3-[[(2S)-4-amino-4-oxo-2-(quinoxaline-2-carbonylamino)butanoyl]amino]-2-hydroxy-4-phenyl-butyl]-2-tert-butyl-N'-(1-ethylpropyl)butanediamide
Canonical SMILES	`CCC(CC)NC(=O)C[C@@H](C(=O)NC[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1cnc2ccccc2n1)C(C)(C)C`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	2
Pfam Stratification	Homologous
Avg pChEMBL	8.72
Source	BindingDB;ChEMBL

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P12497	gag-pol	Human immunodeficiency virus type 1 group M subtype B (isolate NY5)	Pathogen	PF00540 PF19317 PF00552 PF02022 PF00075 PF00665 PF00077 PF00078 PF06815 PF06817 PF00098	8.7	IC50	BindingDB
Q72874	pol	Human immunodeficiency virus type 1	Pathogen	PF00077	8.7	IC50	ChEMBL